Abstract
Methotrexate is one of the most effective drugs commonly used to treat cancer. However, its use is limited due to low solubility, high toxicity, and rapid metabolism. On the other hand, Cyclodextrins improve the physical and chemical properties of complex materials (including solubility) due to their cyclic structure and ability to form host–guest complexes. Therefore, in the present study, β-CD/MTX complex was prepared to increase the solubility and stability of methotrexate in aqueous solvents. The formation of β-CD/MTX host–guest complexes was investigated and confirmed using UV–Vis, XRD, SEM, and PDI analyses. The drug loading and release rate from the β-CD/MTX complex at different pHs was investigated. MTT assay was used to evaluate the toxicity of the complex synthesized on the T47D cell group. Also, using QTAIM theory, the possibility of drug loading and the stability of the formed complex were investigated. The results of this experiment had a good overlap in both theoretical and laboratory sections. The results showed that β-CD has a good capacity for loading and unloading methotrexate molecules. Therefore, it can be used as a nanocarrier to improve the performance of methotrexate.
Similar content being viewed by others
References
Aggarwal P, Hall JB, McLeland CB, Dobrovolskaia MA, McNeil SE (2009) Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy. Adv Drug Deliv Rev 61:428–437. https://doi.org/10.1016/j.addr.2009.03.009
Ali A, Chiang YW, Santos RM (2022) X-ray diffraction techniques for mineral characterization: a review for engineers of the fundamentals, applications, and research directions. Minerals 12:205. https://doi.org/10.3390/min12020205
Bader RFW, Nguyen-Dang TT (1981) Quantum theory of atoms in molecules-dalton revisited. Adv Quantum Chem 14:63–124. https://doi.org/10.1016/S0065-3276(08)60326-3
Braga L, Leal DHS, Kuca K, Ramalho TC (2020) Perspectives on the role of the frontier effective-for-reaction molecular orbital (FERMO) in the study of chemical reactivity: an updated review. Curr Org Chem 24:314–331. https://doi.org/10.2174/1385272824666200204121044
Chamundeeswari M, Jeslin J, Verma ML (2018) Nanocarriers for drug delivery applications. Environ Chem Lett 17(2):849–865
Dewhirst MW, Secomb TW (2017) Transport of drugs from blood vessels to tumour tissue. Nat Rev Cancer 17(12):738–750. https://doi.org/10.1038/nrc.2017.93
Din F, Aman W, Ullah I, Qureshi OS, Mustapha O, Shafique S, Zeb A (2017) Effective use of nanocarriers as drug delivery systems for the treatment of selected tumors. Int J Nanomed 12:7291–7309. https://doi.org/10.2147/IJN.S146315
Ferreira R, Schneekloth JS, Panov KI, HannanK M, Hannan RD (2020) Targeting the RNA polymerase I transcription for cancer therapy comes of age. Cells 9:266. https://doi.org/10.3390/cells9020266
Fifere A, Marangoci N, Maier S, Coroaba A, Maftei D, Pinteala M (2012) Theoretical study on β-cyclodextrin inclusion complexes with propiconazole and protonated propiconazole. Beilstein J Org Chem 8:2191–2201 (PMID: 23365629)
Fröhlich E (2012) The role of surface charge in cellular uptake and cytotoxicity of medical nanoparticles. Int J Nanomed 7:5577–5591. https://doi.org/10.2147/IJN.S36111
Gabriella H, Gyula PS, András S (2013) Hyperthermia versus oncothermia: cellular effects in complementary cancer therapy. Evid Based Complement Alternat Med 2013:672873. https://doi.org/10.1155/2013/672873
Garg S, Huifu H, Kaul SC, Wadhwa R (2018) Integration of conventional cell viability assays for reliable and reproducible read-outs: experimental evidence. BMC Res Notes 11:403. https://doi.org/10.1186/s13104-018-3512-5
Huang C, Ju D, Chang C, Reddy PM, Velmurugan BK (2017) A review on the effects of current chemotherapy drugs and natural agents in treating non–small cell lung cancer. Biomedicine (taipei) 7:23. https://doi.org/10.1051/bmdcn/2017070423
Jang J, Jeong S, Lee Y (2019) Preparation and in vitro/in vivo characterization of polymeric nanoparticles containing methotrexate to improve lymphatic delivery. Int J Mol Sci 20:3312. https://doi.org/10.3390/ijms20133312
Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ (2007) Cancer statistics, 2007. CA Cancer J Clin 57:43–66. https://doi.org/10.3322/canjclin.57.1.43
Kamaly N, Yameen B, Wu J, Farokhzad O (2016) Degradable controlled-release polymers and polymeric nanoparticles: mechanisms of controlling drug release. Chem Rev 116:2602–2663. https://doi.org/10.1021/acs.chemrev.5b00346
Karimi M, Zangabad PS, Mehdizadeh F, Malekzad H, Ghasemi A, Bahrami S, Zare H, Moghoofei M, Hekmatmanesh A, Hamblin MR (2017) Nanocaged platforms: modification, drug delivery and nanotoxicity opening synthetic cages to release the tiger. Nanoscale 9:1356–1392. https://doi.org/10.1039/c6nr07315h
Kato T, Sato K (1988) Drug-carrier complex in targeted cancer chemotherapy. Gan Kagaku Ryoho 15:1031–1037 (PMID: 3291765)
Koźmiński P, Halik PK, Chesori R, Gniazdowska E (2020) Overview of dual-acting drug methotrexate in different neurological diseases, autoimmune pathologies and cancers. Int J Mol Sci 21:3483. https://doi.org/10.3390/ijms21103483
Kumar PSV, Raghavendra V, Subramanian V (2016) Bader’s Theory of atoms in molecules (AIM) and its applications to chemical bonding. J Chem Sci 128:1527–1536. https://doi.org/10.1007/s12039-016-1172-3
Liechty WB, David RK, Brandon VS, Nicholas AP (2010) Polymers for drug delivery systems. Annu Rev Chem Biomol Eng 1:149–173. https://doi.org/10.1146/annurev-chembioeng-073009-100847
Miar M, Shiroudi A (2020) Theoretical investigations on the HOMO–LUMO gap and global reactivity descriptor studies, natural bond orbital, and nucleus-independent chemical shifts analyses of 3-phenylbenzo[d]thiazole-2(3H)-imine and its para-substituted derivatives: solvent and substituent effects. J Chem Res 45:147–158. https://doi.org/10.1177/1747519820932091
Moniruzzaman HMJ, Ahsan A, Hossain MB (2018) Molecular docking, pharmacokinetic and dft calculation of naproxen and its degradants. J Sci Tech Res 9:5. https://doi.org/10.26717/BJSTR.2018.09.001852
Park B, Park S, Kim J, Kim C (2022) Listening to drug delivery and responses via photoacoustic imaging. Adv Drug Deliv Rev 184:114325. https://doi.org/10.1016/j.addr.2022.114235
Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55:74–108. https://doi.org/10.3322/canjclin.55.2.74
Putz MV (2008) Density functionals of chemical bonding. Int J Mol Sci 9:1050–1095. https://doi.org/10.3390/ijms9061050
Rizvi SAA, Saleh AM (2018) Applications of nanoparticle systems in drug delivery technology. Saudi Pharm J 26:64–70. https://doi.org/10.1016/j.jsps.2017.10.012
Senapati S, arunkumarMahanta, Sunil Kumar, PralayMaiti, (2018) Controlled drug delivery vehicles for cancer treatment and their performance. Signal Transduct Target Ther. 3:7. https://doi.org/10.1038/s41392-017-0004-3
Shaik S, Danovich D, Hiberty PC (2021) Valence bond theory—its birth, struggles with molecular orbital theory, its present state and future prospects. Molecules 26:1624. https://doi.org/10.3390/molecules26061624
Sharp H, Nesbit M, White J, Krivit W (1969) Methotrexate liver toxicity. J Pediatr 74:818–819. https://doi.org/10.1016/s0022-3476(69)80160-5
Szente L, Szemán J (2013) Cyclodextrins are utilized in many diverse fields of analytical chemistry, due to their propensity to form reversible inclusion complexes and recognize analytes selectively. This feature shows how these nanocavities can serve analysts in sample preparation, sensitivity and selectivity improvement, enantio-separation, creating single-molecule sensors, and automatizing DNA sequencing. Anal Chem 85:8024–8030. https://doi.org/10.1021/ac400639y
Tejashri G, Amrita B, Darshana J (2013) Cyclodextrin based nanosponges for pharmaceutical use: a review. Acta Pharm 63:335–358. https://doi.org/10.2478/acph-2013-0021
Tiwari G, Tiwari R, Rai AK (2010) Cyclodextrins in delivery systems: Applications. J Pharm Bioallied Sci 2:72–79. https://doi.org/10.4103/0975-7406.67003
Tiwari G, Tiwari R, Sriwastawa B, Bhati L, Pandey S, Pandey P, Bannerjee SK (2012) Drug delivery systems: an updated review. Int J Pharm Investig 2:2–11. https://doi.org/10.4103/2230-973X.96920
Wang S, Liu R, Fu Y, Kao WJ (2020) Release mechanisms and applications of drug delivery systems for extended-release. Expert Opin Drug Deliv 17:1289–1304. https://doi.org/10.1080/17425247.2020.1788541
Xiaoren T, Feng C, Weiyuan M, Yinian T, Bushra A, Mansour A, Erdjan S, Serge D (2020) Cancer cells resist hyperthermia due to its obstructed activation of caspase 3. Rep Pract Oncol Radiother 25:323–326. https://doi.org/10.1016/j.rpor.2020.02.008
Zarepour A, Zarrabi A, Larsen KL (2019) Fabricating β-cyclodextrin based pH-responsive nanotheranostics as a programmable polymeric nanocapsule for simultaneous diagnosis and therapy. Int J Nanomed 14:7017–7038. https://doi.org/10.2147/IJN.S221598
Funding
This study has no funding sponsor.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Hadi, H., Safari, R. & Shamlouei, H.R. Synthesis and experimental/theoretical evaluation of β-CD/MTX nanostructure for use in targeted drug delivery systems. Chem. Pap. 77, 63–74 (2023). https://doi.org/10.1007/s11696-022-02459-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11696-022-02459-8